THOMSON, David J. et al. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma. Acta Oncologica, [S. l.], v. 54, n. 1, p. 88–98, 2015. DOI: 10.3109/0284186X.2014.958528. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/25772. Acesso em: 18 may. 2026.